As of 2025-09-17, the Relative Valuation of Arcturus Therapeutics Holdings Inc (ARCT) is (30.53) USD. This relative valuation is based on P/E multiples. With the latest stock price at 18.09 USD, the upside of Arcturus Therapeutics Holdings Inc based on Relative Valuation is -268.7%.
The range of the Relative Valuation is (30.45) - (30.67) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 13.7x - 13.9x | 13.8x |
| Forward P/E multiples | 13.7x - 13.8x | 13.8x |
| Fair Price | (30.45) - (30.67) | (30.53) |
| Upside | -268.3% - -269.5% | -268.7% |
| Date | P/E |
| 2025-09-12 | -7.82 |
| 2025-09-11 | -8.14 |
| 2025-09-10 | -8.12 |
| 2025-09-09 | -8.10 |
| 2025-09-08 | -8.05 |
| 2025-09-05 | -8.06 |
| 2025-09-04 | -7.56 |
| 2025-09-03 | -7.76 |
| 2025-09-02 | -7.54 |
| 2025-08-29 | -7.68 |
| 2025-08-28 | -7.81 |
| 2025-08-27 | -7.80 |
| 2025-08-26 | -7.92 |
| 2025-08-25 | -7.99 |
| 2025-08-22 | -8.35 |
| 2025-08-21 | -7.89 |
| 2025-08-20 | -7.83 |
| 2025-08-19 | -7.68 |
| 2025-08-18 | -8.08 |
| 2025-08-15 | -8.79 |
| 2025-08-14 | -8.68 |
| 2025-08-13 | -8.67 |
| 2025-08-12 | -6.72 |
| 2025-08-11 | -5.14 |
| 2025-08-08 | -5.37 |
| 2025-08-07 | -5.41 |
| 2025-08-06 | -5.51 |
| 2025-08-05 | -5.34 |
| 2025-08-04 | -5.51 |
| 2025-08-01 | -5.55 |
| 2025-07-31 | -5.51 |
| 2025-07-30 | -5.72 |
| 2025-07-29 | -5.89 |
| 2025-07-28 | -6.49 |
| 2025-07-25 | -6.74 |
| 2025-07-24 | -6.75 |
| 2025-07-23 | -6.97 |
| 2025-07-22 | -6.56 |
| 2025-07-21 | -6.22 |
| 2025-07-18 | -6.09 |
| 2025-07-17 | -6.11 |
| 2025-07-16 | -5.80 |
| 2025-07-15 | -5.93 |
| 2025-07-14 | -6.01 |
| 2025-07-11 | -6.22 |
| 2025-07-10 | -6.53 |
| 2025-07-09 | -6.67 |
| 2025-07-08 | -6.23 |
| 2025-07-07 | -6.03 |
| 2025-07-03 | -6.22 |